Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
Holding RKDA?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.89Last Year’s EPS
-2.1Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2018
|% Change Since: 18.16%
|Next Earnings Date:Aug 08, 2018
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment, characterized by significant revenue growth and expansion in the Zola brand, coupled with improved cash management and operating efficiency. However, challenges such as inventory write-downs and the decline in GLA oil sales were noted. The inability to provide forward-looking guidance due to recent rapid expansion introduces some uncertainty.Company Guidance
During the third quarter 2024 earnings call for Arcadia Biosciences, the company reported an 18% year-over-year increase in total revenues, largely driven by a 55% growth in Zola coconut water sales. This was accompanied by a notable 68% rise in Zola's retail store count compared to the previous year. Despite an increase in selling, general, and administrative expenses by $380,000 due to severance and transition-related fees, the company's cash usage declined to $1.5 million, marking the lowest quarterly cash burn since going public. Zola's performance outpaced the coconut water category, with scan data indicating a 36% increase in sell-through. The company also highlighted a promising outlook, with plans for new product innovations and continued efforts to optimize their cost structure and expand distribution.Revenue Growth
Total revenues increased by 18% year-over-year, driven by a 55% increase in Zola coconut water sales.
Zola Expansion
Zola retail store count increased by 68% compared to the same period last year, achieving the largest quarterly rate of distribution gains in the company's history.
Market Performance
Zola grew faster than the coconut water category across all measured time periods, with a 73% increase in September while the category grew 28%.
Reduced Cash Usage
Use of cash during the quarter declined to $1.5 million, marking the lowest level of cash used in a quarter since Arcadia went public.
Operating Efficiency
Despite revenue growth, selling, general, and administrative expenses were maintained, with increases driven by one-time transition-related fees.
---
RKDA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
RKDA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $4.24 | $4.19 | -1.18% |
| Aug 13, 2024 | $2.99 | $2.66 | -11.04% |
| May 09, 2024 | $2.08 | $2.06 | -0.96% |
| Mar 28, 2024 | $2.21 | $2.05 | -7.24% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Arcadia Biosciences (RKDA) report earnings?
Arcadia Biosciences (RKDA) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Arcadia Biosciences (RKDA) earnings time?
Arcadia Biosciences (RKDA) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RKDA EPS forecast?
RKDA EPS forecast for the fiscal quarter 2024 (Q4) is -0.89.
---